miR-93 has also been shown to target SIRT1 in rats with streptozotocin-induced diabetes, thereby contributing to changes indicative of oxidative stress and inflammation, which can be reversed by SIRT1 overexpression [94]. Here, SIRT1 is linked to diabetes mellitus.